Metraipolis › archive › dc_df2b71cb69c8

Chimeric Antigen Receptor T-Cell Therapy: What We Expect Soon — Europe PMC PMID:36362130

Source: Europe PMC (en)
Original: https://europepmc.org/article/MED/36362130
DOI: 10.3390/ijms232113332
License (as archived): solo-consultazione
Archived: 2026-10-08T14:40:39.677Z
SHA-256 of the archived text: 3c6237b6553a037ab74ffdc72ab7868d78d80b7cc162d877d4240cbd4fa164fb
Stable URL of this page: https://metraipolis.com/documento/dc_df2b71cb69c8

How to cite

Chimeric Antigen Receptor T-Cell Therapy: What We Expect Soon — Europe PMC PMID:36362130 — Europe PMC (en), https://europepmc.org/article/MED/36362130 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_df2b71cb69c8 (Metraipolis archive dc_df2b71cb69c8, sha256 3c6237b6553a037ab74ffdc72ab7868d78d80b7cc162d877d4240cbd4fa164fb)

BibTeX

@misc{dcdf2b71cb69c8,
  title = {Chimeric Antigen Receptor T-Cell Therapy: What We Expect Soon — Europe PMC PMID:36362130},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/36362130},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_df2b71cb69c8; sha256 3c6237b6553a037ab74ffdc72ab7868d78d80b7cc162d877d4240cbd4fa164fb},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/36362130. Agents can read the archived copy with the MCP tool read_document.